Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+24.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+24.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 86.54% |
| 2023 | 55.38% |
| 2022 | 23.67% |
| 2021 | 44.77% |
| 2020 | 45.91% |
| 2019 | -4.68% |
| 2018 | -22.70% |
| 2017 | -48.31% |
| 2016 | 0.00% |